Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSLLY | REGN | ARGX | ||
| Company | Csl Ltd ADR | Regeneron Pharmaceuticals | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 62.1918 | 741.59 | 885.45 | ||
| High | 62.1918 | 746.05 | 887.60 | ||
| Low | 60.6700 | 734.99 | 875.60 | ||
| Latest | 61.3520 | 739.87 | 878.32 | ||
| Change | +1.3020 | -6.93 | -11.17 | ||
| % Change | +2.17% | -0.93% | -1.26% | ||
| Volume | 95,580 | 352,238 | 145,432 | ||
| 20-Day Average Volume | 150,833 | 1,103,979 | 333,507 | ||
| Previous Close | 60.0500 | 746.80 | 889.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 59.7142 | 734.81 | 908.21 | ||
| 20-Day Raw Stochastic | 67.02% | 49.65% | 9.52% | ||
| 20-Day Relative Strength | 49.12 | 59.26 | 53.51 | ||
| Weighted Alpha | -32.61 | +14.42 | +55.58 | ||
| Today's Opinion | 88% Sell | 100% Buy | 80% Buy | ||
| Previous Opinion | 88% Sell | 100% Buy | 80% Buy | ||
| Last Month's Opinion | 100% Sell | 72% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.79% since 12/05/25 | +2.75% since 12/05/25 | -2.03% since 12/05/25 | ||
| Low | 57.2200 on 12/11/25 | 691.86 on 12/09/25 | 877.40 on 12/12/25 | ||
| High | 62.1918 on 12/12/25 | 753.61 on 12/11/25 | 917.71 on 12/08/25 | ||
| 1-Month | |||||
| %Chg | +4.61% since 11/12/25 | +8.27% since 11/12/25 | -0.79% since 11/12/25 | ||
| Low | 56.2300 on 11/18/25 | 679.93 on 11/13/25 | 877.40 on 12/12/25 | ||
| High | 63.7200 on 12/04/25 | 790.98 on 11/26/25 | 934.62 on 12/03/25 | ||
| 3-Month | |||||
| %Chg | -10.48% since 09/12/25 | +31.80% since 09/12/25 | +16.72% since 09/12/25 | ||
| Low | 54.1000 on 10/29/25 | 541.00 on 10/13/25 | 698.92 on 09/25/25 | ||
| High | 72.5700 on 10/22/25 | 790.98 on 11/26/25 | 934.62 on 12/03/25 | ||
| 6-Month | |||||
| %Chg | -22.61% since 06/12/25 | +41.44% since 06/12/25 | +50.46% since 06/12/25 | ||
| Low | 54.1000 on 10/29/25 | 503.25 on 06/18/25 | 510.05 on 06/30/25 | ||
| High | 89.7100 on 07/29/25 | 790.98 on 11/26/25 | 934.62 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 58,266,696 | 78,487,928 | 54,765,008 | ||
| Shares Outstanding, K | 970,303 | 105,099 | 61,569 | ||
| Annual Sales | 15,558,000,000 | 14,202,000,000 | 2,252,040,000 | ||
| Annual Net Income | 3,002,000,000 | 4,412,600,000 | 833,040,000 | ||
| Last Quarter Sales | N/A | 3,754,300,000 | 1,151,340,000 | ||
| Last Quarter Net Income | N/A | 1,460,000,000 | 344,260,000 | ||
| 60-Month Beta | 0.77 | 0.37 | 0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 11.83 on 10/28/25 | 5.18 on 10/30/25 | ||
| Latest Earnings Date | 01/01/70 | 02/03/26 | 02/26/26 | ||
| Most Recent Dividend | 0.760 on 09/10/25 | 0.880 on 11/20/25 | N/A | ||
| Next Ex-Dividends Date | 09/10/25 | 11/20/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.80 | 68.05 | ||